GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BUE:MRK) » Definitions » Cyclically Adjusted Book per Share

Merck (BUE:MRK) Cyclically Adjusted Book per Share : ARS4,477.06 (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Merck Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Merck's adjusted book value per share for the three months ended in Mar. 2025 was ARS204,790.370. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ARS4,477.06 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Merck's average Cyclically Adjusted Book Growth Rate was -0.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 0.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 1.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Merck was 11.30% per year. The lowest was -1.00% per year. And the median was 6.90% per year.

As of today (2025-05-24), Merck's current stock price is ARS18000.00. Merck's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ARS4,477.06. Merck's Cyclically Adjusted PB Ratio of today is 4.02.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Merck was 7.82. The lowest was 3.04. And the median was 4.63.


Merck Cyclically Adjusted Book per Share Historical Data

The historical data trend for Merck's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Cyclically Adjusted Book per Share Chart

Merck Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 484.52 664.49 1,144.62 3,277.84 3,974.81

Merck Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,692.97 4,705.44 4,209.11 3,974.81 4,477.06

Competitive Comparison of Merck's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, Merck's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Cyclically Adjusted PB Ratio falls into.


;
;

Merck Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=204790.37/134.9266*134.9266
=204,790.370

Current CPI (Mar. 2025) = 134.9266.

Merck Quarterly Data

Book Value per Share CPI Adj_Book
201506 1,494.532 100.684 2,002.824
201509 1,529.577 100.392 2,055.758
201512 2,079.160 99.792 2,811.176
201603 2,309.916 100.470 3,102.099
201606 2,191.613 101.688 2,907.979
201609 2,362.776 101.861 3,129.768
201612 2,311.959 101.863 3,062.404
201703 2,241.126 102.862 2,939.734
201706 2,385.900 103.349 3,114.893
201709 2,458.329 104.136 3,185.212
201712 2,431.371 104.011 3,154.054
201803 2,519.523 105.290 3,228.723
201806 3,038.431 106.317 3,856.071
201809 4,487.453 106.507 5,684.870
201812 3,883.271 105.998 4,943.084
201903 4,167.520 107.251 5,242.953
201906 4,810.286 108.070 6,005.723
201909 5,883.993 108.329 7,328.640
201912 6,099.025 108.420 7,590.112
202003 6,444.214 108.902 7,984.242
202006 7,482.183 108.767 9,281.701
202009 8,565.115 109.815 10,523.725
202012 8,142.728 109.897 9,997.294
202103 9,588.771 111.754 11,576.996
202106 12,452.633 114.631 14,657.340
202109 13,859.381 115.734 16,157.692
202112 15,256.378 117.630 17,499.787
202203 17,361.677 121.301 19,311.894
202206 20,540.856 125.017 22,169.083
202209 24,383.890 125.227 26,272.677
202212 30,381.826 125.222 32,736.444
202303 36,462.027 127.348 38,631.977
202306 36,568.521 128.729 38,329.185
202309 56,932.493 129.860 59,153.991
202312 53,588.957 129.419 55,869.335
202403 134,270.425 131.776 137,480.455
202406 153,915.881 132.554 156,671.076
202409 167,056.272 133.029 169,439.383
202412 185,058.515 133.157 187,517.723
202503 204,790.370 134.927 204,790.370

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Merck  (BUE:MRK) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Merck's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=18000.00/4477.06
=4.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Merck was 7.82. The lowest was 3.04. And the median was 4.63.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Merck Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Merck's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck Business Description

Industry
Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.